🧪 GLP-1 Agonists

Everything about GLP-1 agonists: how they work, research, effectiveness for weight loss. Tirzepatide, semaglutide, liraglutide.

15 articles

Саксенда (Saxenda) ліраглутид — ін'єкційна ручка поряд з Мунджаро KwikPen, порівняння GLP-1 препаратів для схуднення
🧪GLP-1 Agonists
10 min
10 min read

Saxenda (Liraglutide): Complete 2026 Guide — Why Daily Injections Fall Behind New GLP-1s

Saxenda works, but requires daily injections and delivers half the results of Mounjaro. We break down the mechanism, dosing, side effects, and why patients are switching to more powerful medications.

D
DOZA Team
saxendaliraglutide
Інгібітори міостатину Мунджаро (Mounjaro) — ручка KwikPen та анатомія м'язового волокна, майбутнє схуднення без втрати м'язів
🔬Research
9 min
9 min read

Weight Loss Without Muscle Loss: How Myostatin Inhibitors Will Transform Mounjaro and Ozempic Treatment

The EMBRAZE 2026 study showed: apitegromab preserves 54.9% more muscle mass during weight loss on tirzepatide. What this means for Mounjaro and Ozempic users.

D
DOZA Team
myostatin inhibitorsapitegromab
Кагрісема (CagriSema) та Оземпік (Ozempic) — порівняння продуктів для схуднення на білому фоні, преміум фармацевтична фотографія
🧪GLP-1 Agonists
11 min
11 min read

CagriSema: Will the New Duo Outperform Mounjaro and Ozempic

CagriSema combines semaglutide with amylin and shows 22.7% weight loss. But will it beat tirzepatide? We analyze the REDEFINE and REIMAGINE results.

D
DOZA Team
cagrisemaamylin
Мунджаро (Mounjaro) та силові тренування — жінка у спортзалі з протеїновим коктейлем та упаковкою препарату
Weight Loss
13 min
13 min read

Why You Lose Muscle on Mounjaro and Ozempic — and How to Prevent It

Up to 40% of weight lost on GLP-1 medications can be muscle. But this is preventable. We break down the 2025-2026 protocol: protein, resistance training, creatine, and peptides.

D
DOZA Team
mounjaro muscleozempic muscle loss
Орфорглипрон (Foundayo) таблетка vs Мунджаро (Mounjaro) та Оземпік (Ozempic) — порівняння GLP-1 для схуднення
🧪GLP-1 Agonists
10 min
10 min read

Orforglipron (Foundayo): The First Weight Loss Pill You Can Take Without Restrictions — What the Studies Show

Orforglipron was approved by the FDA in April 2026. We compare it with Mounjaro and Ozempic: effectiveness 12.4% vs 22.5%, side effects, and when it will be available in Ukraine.

D
DOZA Team
orforglipronfoundayo
Retatrutide dosing 2.5→5→10mg - three ALLUVI pens with different doses from DOZA
🧪GLP-1 Agonists
13 min
13 min read

Retatrutide Dosing: Complete Guide from 2.5 mg to 12 mg Without Setbacks

How to properly increase retatrutide dose to avoid side effects and achieve maximum results: practical step-by-step protocol.

D
DOZA Team
retatrutidepeptide dosing
💊

Ready to lose weight with Mounjaro?

Free specialist consultation — we'll select the right dose and program for you

Consultation →
Woman в pharmacy compares Synedica Retatrutide та Mounjaro KwikPen — який препарат choose DOZA
🧪GLP-1 Agonists
13 min
13 min read

Retatrutide vs Mounjaro: Which Weight Loss Medication to Choose in 2025-2026

Triple agonist vs dual agonist: Understanding how Retatrutide differs from Mounjaro and which product suits each person for weight management.

D
DOZA Team
retatrutidemounjaro
Retatrutide side effects - SYNEDICA and ALLUVI products on DOZA specialist's desk
🧪GLP-1 Agonists
10 min
10 min read

Retatrutide Side Effects: Complete Analysis vs Mounjaro and Ozempic

What to expect on Retatrutide, side effect profile, and how the triple mechanism changes the experience compared to Mounjaro and Ozempic.

D
DOZA Team
retatrutideside effects
ALLUVI Retatrutide injection pen - triple GLP-1/GIP/glucagon agonist for DOZA weight loss program
🧪GLP-1 Agonists
13 min
13 min read

Retatrutide: Why the Triple Agonist is Called the "Heavy Artillery" of Weight Loss

The first drug to activate three receptors simultaneously: GLP-1, GIP, and glucagon. Minus 24% weight in 48 weeks — but should you start with this one?

D
DOZA Team
retatrutidetriple agonist
Ozempic (Ozempic) semaglutide безпека — woman з resultом program weight loss DOZA Ukraine
Семаглутід пройшов випробування на понад 40 000 пацієнтів
🧪GLP-1 Agonists
7 min
7 min read

Is Ozempic Safe? 40,000 Patients, SELECT Study & Honest Answer

Ozempic isn't just safe. The SELECT study proved it reduces cardiovascular events by 20%. We address all concerns with data.

D
DOZA Team
ozempicsemaglutide
Retatrutide triple GLP-1+GIP+glucagon agonist — woman showing weight loss results from DOZA program
Ретатрутид — найпотужніший GLP-1 препарат нового покоління
🧪GLP-1 Agonists
7 min
7 min read

Retatrutide: Triple Mechanism That Changes Weight Loss Rules

Retatrutide is the first triple GLP-1+GIP+glucagon agonist with -24.2% weight loss results. How the third receptor works and where to try it in Ukraine.

Портрет Анастасії Шаповал спеціаліст DOZA з метаболічних програм та контролю вагиAnastasiia Shapoval
retatrutidetriple agonist
Woman receiving original Tirzepatide Mounjaro product at DOZA pharmacy Ukraine
Оригінальний Мунджаро (Mounjaro) з тирзепатідом доступний в Україні через DOZA
🧪GLP-1 Agonists
7 min
7 min read

Tirzepatide: The First Dual-Action Molecule That Changed Weight Loss Rules

Tirzepatide activates two hormonal receptors instead of one. Result — record-breaking -22.5% weight loss in clinical trials. Why does this work better than everything else?

Портрет Анастасії Шаповал спеціаліст DOZA з метаболічних програм та контролю вагиAnastasiia Shapoval
tirzepatidemounjaro